BCLI Insider Trading

14.33% of Brainstorm Cell Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Brainstorm Cell Therapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
4/15/2024	Kingswood Wealth Advisors LLC	81,050	$46K	0.0%	N/A	0.119%
11/16/2023	GTS Securities LLC	202,720	$41K	0.0%	N/A	0.450%
8/15/2023	Wells Fargo & Company MN	37,354	$77K	0.0%	+50.6%	0.095%
8/15/2023	Worth Venture Partners LLC	175,563	$0.36M	0.2%	-51.1%	0.445%
8/14/2023	Mirador Capital Partners LP	25,084	$52K	0.0%	N/A	0.064%
8/14/2023	Marshall Wace LLP	67,418	$0.14M	0.0%	N/A	0.171%
8/11/2023	Renaissance Technologies LLC	206,800	$0.43M	0.0%	N/A	0.525%
8/11/2023	BlackRock Inc.	485,464	$1M	0.0%	+2.4%	1.232%
8/9/2023	Kingswood Wealth Advisors LLC	16,600	$34K	0.0%	N/A	0.042%
7/31/2023	LPL Financial LLC	41,541	$86K	0.0%	N/A	0.105%
7/31/2023	Socha Financial Group LLC	12,380	$26K	0.0%	N/A	0.031%
7/26/2023	Janney Montgomery Scott LLC	20,000	$41K	0.0%	N/A	0.051%
7/12/2023	Professional Financial Advisors LLC	17,279	$36K	0.0%	N/A	0.044%
5/15/2023	AIGH Capital Management LLC	1,459,095	$4.82M	1.8%	N/A	3.978%
5/15/2023	XTX Topco Ltd	12,227	$40K	0.0%	N/A	0.033%
5/10/2023	Nelson Van Denburg & Campbell Wealth Management Group LLC	12,686	$42K	0.0%	N/A	0.035%
5/9/2023	Tower Research Capital LLC TRC	8,862	$29K	0.0%	+739.2%	0.024%
5/3/2023	Liberty Wealth Management LLC	150,400	$0.50M	0.1%	N/A	0.410%
4/26/2023	TRU Independence Asset Management 2 LLC	44,000	$0.15M	0.1%	N/A	0.120%
4/14/2023	Raymond James Financial Services Advisors Inc.	11,248	$37K	0.0%	N/A	0.031%
4/14/2023	Raymond James & Associates	164,703	$0.54M	0.0%	-22.6%	0.449%
2/15/2023	Millennium Management LLC	41,618	$68K	0.0%	-71.0%	0.114%
2/15/2023	Morgan Stanley	24,096	$40K	0.0%	-34.0%	0.066%
2/14/2023	Marshall Wace LLP	37,582	$62K	0.0%	+188.6%	0.103%
2/10/2023	Creative Planning	25,681	$42K	0.0%	-16.3%	0.070%
2/8/2023	Raymond James & Associates	212,703	$0.35M	0.0%	-13.1%	0.582%
11/15/2022	Liberty Wealth Management LLC	40,000	$0.18M	0.0%	+33.3%	0.110%
11/15/2022	Price T Rowe Associates Inc. MD	108,000	$0.48M	0.0%	+16.1%	0.296%
11/15/2022	Marshall Wace LLP	13,024	$58K	0.0%	N/A	0.036%
11/14/2022	Renaissance Technologies LLC	55,700	$0.25M	0.0%	+225.7%	0.153%
11/14/2022	Boothbay Fund Management LLC	19,098	$84K	0.0%	-31.5%	0.052%
11/8/2022	IFP Advisors Inc	28,850	$0.15M	0.0%	+45.3%	0.079%
11/3/2022	Creative Planning	30,681	$0.14M	0.0%	N/A	0.084%
10/31/2022	TRU Independence Asset Management 2 LLC	44,000	$0.19M	0.2%	N/A	0.121%
10/25/2022	Janney Montgomery Scott LLC	20,000	$88K	0.0%	N/A	0.055%
10/25/2022	Raymond James & Associates	244,803	$1.08M	0.0%	+30.6%	0.671%
10/20/2022	Jmac Enterprises LLC	40,430	$0.18M	0.1%	-11.0%	0.111%
10/6/2022	Abner Herrman & Brock LLC	280,000	$1.24M	0.2%	+5.7%	0.767%
8/16/2022	Jane Street Group LLC	12,085	$33K	0.0%	N/A	0.033%
8/15/2022	Millennium Management LLC	109,996	$0.30M	0.0%	-22.1%	0.301%
8/13/2022	Virtu Financial LLC	20,702	$57K	0.0%	N/A	0.057%
8/13/2022	Renaissance Technologies LLC	17,100	$47K	0.0%	N/A	0.047%
8/12/2022	Ikarian Capital LLC	253,432	$0.70M	0.1%	-16.7%	0.695%
8/11/2022	JPMorgan Chase & Co.	187,070	$0.52M	0.0%	-24.0%	0.513%
7/20/2022	Weaver Consulting Group	104,653	$0.29M	0.2%	-19.5%	0.287%
7/11/2022	S.C. Financial Services Inc.	25,471	$70K	0.1%	+66.6%	0.070%
5/16/2022	State Street Corp	96,060	$0.32M	0.0%	+10.8%	0.263%
5/16/2022	UBS Group AG	7,706	$26K	0.0%	-46.5%	0.021%
5/13/2022	Vanguard Group Inc.	1,421,099	$4.78M	0.0%	-0.7%	3.894%
5/11/2022	JPMorgan Chase & Co.	246,202	$0.83M	0.0%	+27.5%	0.675%
5/6/2022	Weaver Consulting Group	130,000	$0.44M	0.2%	-16.4%	0.356%
4/7/2022	Abner Herrman & Brock LLC	265,000	$0.89M	0.1%	+13.7%	0.726%
2/9/2022	Geneos Wealth Management Inc.	10,100	$40K	0.0%	N/A	0.028%
2/8/2022	Steward Partners Investment Advisory LLC	9,700	$39K	0.0%	-42.9%	0.027%
2/8/2022	Raymond James & Associates	189,503	$0.76M	0.0%	-11.4%	0.522%
2/2/2022	Aptus Capital Advisors LLC	12,500	$50K	0.0%	-21.9%	0.034%
2/1/2022	Weaver Consulting Group	155,500	$0.62M	0.3%	+201.9%	0.429%
1/26/2022	S.C. Financial Services Inc.	15,285	$52K	0.1%	N/A	0.042%
1/13/2022	Abner Herrman & Brock LLC	233,000	$0.93M	0.1%	+13.7%	0.642%
11/15/2021	GSA Capital Partners LLP	172,056	$0.57M	0.1%	+185.6%	0.474%
11/9/2021	BlackRock Inc.	468,967	$1.55M	0.0%	-1.1%	1.293%
10/6/2021	Abner Herrman & Brock LLC	205,000	$0.68M	0.1%	-15.1%	0.564%
8/17/2021	Millennium Management LLC	371,460	$1.41M	0.0%	N/A	1.023%
8/17/2021	Price T Rowe Associates Inc. MD	93,000	$0.35M	0.0%	-23.9%	0.256%
8/16/2021	LMR Partners LLP	11,735	$45K	0.0%	N/A	0.032%
8/16/2021	Charles Schwab Investment Management Inc.	11,287	$43K	0.0%	-85.6%	0.031%
8/16/2021	State Street Corp	86,703	$0.33M	0.0%	-83.2%	0.239%
8/16/2021	Tibra Equities Europe Ltd	87,000	$0.33M	0.1%	N/A	0.240%
8/16/2021	Goldman Sachs Group Inc.	57,679	$0.22M	0.0%	+144.4%	0.159%
8/13/2021	Renaissance Technologies LLC	47,600	$0.18M	0.0%	N/A	0.131%
8/13/2021	Steward Partners Investment Advisory LLC	19,000	$72K	0.0%	-38.3%	0.052%
8/13/2021	Northern Trust Corp	49,761	$0.19M	0.0%	-83.4%	0.137%
8/13/2021	Geode Capital Management LLC	265,138	$1.01M	0.0%	-44.6%	0.730%
8/13/2021	Vanguard Group Inc.	1,412,826	$5.37M	0.0%	+6.2%	3.890%
8/12/2021	JPMorgan Chase & Co.	698,294	$2.65M	0.0%	-13.3%	1.923%
8/12/2021	Ergoteles LLC	124,329	$0.47M	0.0%	N/A	0.342%
8/11/2021	Bank of New York Mellon Corp	15,899	$61K	0.0%	-82.1%	0.044%
8/11/2021	BlackRock Inc.	474,347	$1.80M	0.0%	-75.7%	1.306%
8/5/2021	GSA Capital Partners LLP	60,238	$0.23M	0.0%	+137.7%	0.166%
8/2/2021	Advisor Group Holdings Inc.	10,920	$42K	0.0%	-54.5%	0.030%
6/5/2021	Advisory Services Network LLC	10,000	$38K	0.0%	N/A	0.028%
5/18/2021	Voloridge Investment Management LLC	87,393	$0.34M	0.0%	-75.6%	0.241%
5/18/2021	Cubist Systematic Strategies LLC	10,992	$42K	0.0%	N/A	0.030%
5/18/2021	IHT Wealth Management LLC	10,000	$38K	0.0%	-23.1%	0.028%
5/17/2021	Schonfeld Strategic Advisors LLC	12,400	$48K	0.0%	-36.4%	0.034%
5/17/2021	Price T Rowe Associates Inc. MD	122,161	$0.47M	0.0%	+460.2%	0.336%
5/17/2021	Ikarian Capital LLC	293,200	$1.12M	0.0%	N/A	0.807%
5/17/2021	Goldman Sachs Group Inc.	23,604	$90K	0.0%	-23.4%	0.065%
5/13/2021	Barclays PLC	25,500	$98K	0.0%	+193.4%	0.070%
5/12/2021	Northern Trust Corp	299,433	$1.15M	0.0%	-1.7%	0.824%
5/12/2021	Geode Capital Management LLC	478,258	$1.83M	0.0%	+17.8%	1.317%
5/12/2021	JPMorgan Chase & Co.	805,438	$3.09M	0.0%	+105.3%	2.218%
5/12/2021	UBS Group AG	16,298	$63K	0.0%	+43.9%	0.045%
5/11/2021	New York State Common Retirement Fund	15,000	$57K	0.0%	+163.2%	0.041%
5/10/2021	HighTower Advisors LLC	10,516	$40K	0.0%	N/A	0.029%
5/10/2021	GSA Capital Partners LLP	25,344	$97K	0.0%	N/A	0.070%
5/10/2021	Phoenix Holdings Ltd.	56,821	$0.21M	0.0%	-67.3%	0.156%
5/7/2021	BlackRock Inc.	1,953,247	$7.48M	0.0%	+1.7%	5.378%
5/6/2021	Aptus Capital Advisors LLC	16,050	$61K	0.0%	-53.0%	0.044%
5/6/2021	Alliancebernstein L.P.	23,000	$88K	0.0%	-22.6%	0.063%

Data available starting January 2016

Brainstorm Cell Therapeutics Inc., a biotechnology company, engages in the development and commercialization of autologous cellular therapies for the treatment of neurodegenerative diseases. The company, through its NurOwn proprietary cell therapy platform, leverages cell culture methods to induce autologous bone marrow-derived mesenchymal stem cells to secrete high levels of neurotrophic factors, modulate neuroinflammatory and neurodegenerative disease processes, promote neuronal survival, and enhance neurological function. It is developing NurOwn, which has completed Phase III clinical trial for the treatment of amyotrophic lateral sclerosis; Phase II clinical trial for the treatment of progressive multiple sclerosis; and for the treatment of alzheimer's disease, as well as for other neurodegenerative diseases. The company was formerly known as Golden Hand Resources Inc. and changed its name to Brainstorm Cell Therapeutics Inc. in November 2004. Brainstorm Cell Therapeutics Inc. was incorporated in 2000 and is headquartered in New York, New York.

Today's Range

Now: $0.55

$0.54

$0.60

50 Day Range

MA: $0.45

$0.31

$0.74

52 Week Range

Now: $0.55

$0.13

$3.37

Volume

589,469 shs

Average Volume

1,027,674 shs

Market Capitalization

$37.50 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.27

Who are the company insiders with the largest holdings of Brainstorm Cell Therapeutics?: Brainstorm Cell Therapeutics' top insider shareholders include:
Stacy Lindborg (CEO)
Learn More about top insider investors at Brainstorm Cell Therapeutics.
Who are the major institutional investors of Brainstorm Cell Therapeutics?: Brainstorm Cell Therapeutics' top institutional investors include:
Kingswood Wealth Advisors LLC — 0.12%
Learn More about top institutional investors of Brainstorm Cell Therapeutics stock.
Which major investors are buying Brainstorm Cell Therapeutics stock?: During the last quarter, BCLI stock was acquired by institutional investors including:
Kingswood Wealth Advisors LLC